2026 Bernard Moss: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Best Scientists	179	634	584	395	357	875	108272
Immunology	180	37	34	26	24	862	109656
Medicine	180	371	336	234	209	868	109905

Research.com Recognitions

2026 - Research.com Immunology in United States Leader Award
2025 - Research.com Best Scientists Award
2025 - Research.com Immunology in United States Leader Award
1998 - Fellow of the American Association for the Advancement of Science (AAAS)
1987 - Member of the National Academy of Sciences

Overview

Bernard Moss is affiliated with the National Institutes of Health in the United States. Their research primarily focuses on immunology and microbiology, medicine, and biochemistry, genetics, and molecular biology. Within these fields, the scientist has contributed extensively to virology, epidemiology, molecular biology, genetics, and infectious diseases.

The scientist's main topics of work cover several areas including:

Poxvirus research and outbreaks
Herpesvirus infections and treatments
Virus-based gene therapy research
Bacillus and Francisella bacterial research
Plant virus research studies
Bacteriophages and microbial interactions
SARS-CoV-2 and COVID-19 research

Bernard Moss has collaborated frequently with several researchers. Notable coauthors include Patricia L. Earl, Jeffrey L. Americo, Catherine A. Cotter, Chen Peng, and Tatiana G. Senkevich.

The scientist has published multiple articles in prominent scientific venues. The most frequent publication outlets are:

bioRxiv (Cold Spring Harbor Laboratory)
Journal of Virology
Proceedings of the National Academy of Sciences
PLoS Pathogens
mBio

Recent notable papers authored or coauthored by Bernard Moss include:

"Virulence differences of mpox (monkeypox) virus clades I, IIa, and IIb.1 in a small animal model" (2023), published in Proceedings of the National Academy of Sciences
"Ancient Gene Capture and Recent Gene Loss Shape the Evolution of Orthopoxvirus-Host Interaction Genes" (2021), published in mBio
"An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challenge" (2023), published in Science Translational Medicine
"Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhuman primates" (2024), published in Cell
"One or two injections of MVA-vectored vaccine shields hACE2 transgenic mice from SARS-CoV-2 upper and lower respiratory tract infection" (2021), published in Proceedings of the National Academy of Sciences

Bernard Moss has received recognition in the form of prestigious awards, including election as a Member of the National Academy of Sciences in 1987 and designation as a Fellow of the American Association for the Advancement of Science (AAAS) in 1998.

Best Publications

Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase

T R Fuerst;E G Niles;F W Studier;B Moss

2644
Citations
Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

Rama Rao Amara;Francois Villinger;John D. Altman;Shari L. Lydy

1465
Citations
HIV-specific cytotoxic T lymphocytes in seropositive individuals.

Bruce D. Walker;Sekhar Chakrabarti;Bernard Moss;Timothy J. Paradis

1042
Citations
Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques.

S Chakrabarti;K Brechling;B Moss

1011
Citations
Vaccinia virus: a selectable eukaryotic cloning and expression vector

Michael Mackett;Geoffrey L. Smith;Bernard Moss

958
Citations
In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity.

R L Willey;D H Smith;L A Lasky;T S Theodore

865
Citations
Nonreplicating vaccinia vector efficiently expresses recombinant genes

Gerd Sutter;Bernard Moss

859
Citations
General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes.

M Mackett;G L Smith;B Moss

840
Citations
Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety

Bernard Moss

832
Citations
Methylated nucleotides block 5' terminus of HeLa cell messenger RNA.

Cha-Mer Wei;Alan Gershowitz;Bernard Moss

818
Citations
Product review. New mammalian expression vectors.

B. Moss;O. Elroy-Stein;T. Mizukami;W. A. Alexander

800
Citations
Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein.

Jeffrey D. Lifson;Jeffrey D. Lifson;Mark B. Feinberg;Gregory R. Reyes;Linda Rabin

779
Citations
Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes

Jonathan W. Yewdell;Jack R. Bennink;Geoffrey L. Smith;Bernard Moss

676
Citations
Compact, Synthetic, Vaccinia Virus Early/Late Promoter for Protein Expression

Sekhar Chakrabarti;Jerry R. Sisler;Bernard Moss

650
Citations
The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis.

B Rehermann;P Fowler;J Sidney

650
Citations
Vaccinia virus: a tool for research and vaccine development

Bernard Moss

612
Citations
GP100/PMEL 17 IS A MURINE TUMOR REJECTION ANTIGEN : INDUCTION OF SELF -REACTIVE, TUMORICIDAL T CELLS USING HIGH-AFFINITY, ALTERED PEPTIDE LIGAND

Willem W. Overwijk;Allan Tsung;Kari R. Irvine;Maria R. Parkhurst

612
Citations
A role for tumor necrosis factor receptor-2 and receptor-interacting protein in programmed necrosis and antiviral responses.

Francis Ka Ming Chan;Francis Ka Ming Chan;Joanna L. Shisler;Jacqueline G. Bixby;Martin Felices

605
Citations
Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen

Geoffrey L. Smith;Michael Mackett;Bernard Moss

604
Citations
Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype

R. M. L. Buller;G. L. Smith;K. Cremer;A. L. Notkins

601
Citations
Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine

Rama Rao Amara;Francois Villinger;John D Altman;Shari L Lydy;Shari L Lydy

137
Citations

Frequent Co-Authors

Patricia L. Earl National Institute of Allergy and Infectious Diseases

Linda S. Wyatt National Institutes of Health

Rama Rao Amara Emory University

David C. Montefiori Duke University

Harriet L. Robinson Emory University

Geoffrey L. Smith University of Oxford

Edward A. Berger National Institutes of Health

Jay A. Berzofsky National Institutes of Health

Francois Villinger University of Louisiana at Lafayette

Eugene V. Koonin National Institutes of Health

External Links

Wikipedia of Bernard Moss Personal website of Bernard Moss

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare fields can expand career opportunities. Nursing professions, especially, offer several pathways that complement immunology knowledge, particularly in clinical care and research roles.

Accredited LPN programs easy to get into serve as a practical starting point for students seeking licensure and foundational nursing skills. These programs provide a quicker route into healthcare roles while building medical knowledge applicable to immunology.

Advancing to a nurse practitioner degree can open specialized roles in patient care. For those seeking accessible educational options, the easiest NP programs to get into offer flexible and supportive pathways to become licensed nurse practitioners.

For specialized mental health roles, programs such as the best PMHNP programs online combine rigorous clinical training with convenient online learning, ensuring graduates are well-prepared for psychiatric nursing careers that often intersect with immunological health.

Cost is a critical factor in education choices. Identifying the cheapest PMHNP programs online allows prospective students to pursue advanced psychiatric nursing credentials while managing their financial investment effectively.

By considering these diverse educational options, students can tailor their learning paths to align with career goals that complement immunology, from direct patient care to mental health specialties.